TEVA FY 2011 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$35B

FY 2011 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$18.3B+13.6% YoY

Gross Profit

$9.5B52.0% margin

Operating Income

$3.1B17.0% margin

Net Income

$2.8B15.1% margin

EPS (Diluted)

$3.09

Cash Flow

Operating Cash Flow

$4.1B

Free Cash Flow

$3.1B

Stock-Based Comp.

$91M

Balance Sheet

Total Assets

$50.1B

Total Liabilities

$27.8B

Stockholders' Equity

$22.2B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18.3B	$16.1B	+13.6%
Gross Profit	$9.5B	$9.1B	+5.0%
Operating Income	$3.1B	$3.9B	-19.7%
Net Income	$2.8B	$3.3B	-17.2%